The impact of the 4-year human recombinant growth hormone treatment on growth, body composition and bone mineral density in patients with isolated growth hormone deficiency and multihormonal pituitary insufficiency
Dominika Januś, Małgorzata Wójcik, Agata Zygmunt-Górska, Katarzyna Doleżal-Ołtarzewska, Jerzy Starzyk